Corona Remedies files draft papers with Sebi for Rs 800 crore IPO

Corona Remedies, an Indian pharmaceutical company, has filed preliminary documents with SEBI to launch an Rs 800-crore IPO. The IPO consists entirely of an offer for sale by promoters and existing investors like Sepia Investments, Anchor Partners and Sage Investment Trust. The company focuses on developing, manufacturing, and marketing pharmaceutical formulations across various therapeutic areas, including women’s healthcare and cardio-diabeto.

  • Adidas freezes 2025 profit guidance amid Trump tariff-induced inflation risk; stock down 12% YTD

  • Sebi extends deadline for implementation of T+0 settlement to 1 Nov

  • SEBI warns investors against unregulated opinion trading platforms, vows strict action

  • BPCL share price: Should you buy this dividend stock after Q4 results 2025? EXPLAINED

  • Vedanta Q4 Results Preview: Net profit expected to jump 140% YoY; Aluminium, Oil & Gas segments to show weakness

  • Market Trading Guide: Mazagon Dock, BEML are among 4 stock recommendations for Wednesday

  • Sebi extends same day T+0 settlement cycle by six months till November 1

  • Capital Small Finance Bank Q4 profit rises 21%, NIM improves to 4.1%

  • SBI board to weigh equity fundraising plan during May 3 results meet

  • Bajaj Finserv Q4 Results: Net profit rises 14% to ₹2,417 crore; 100% dividend declared

  • Airport lounge player Travel Food Services gets Sebi nod for Rs 2,000 crore IPO

  • These 5 stocks hit 52-week high and rally up to 20% in a month

  • Stock market update: Nifty Pharma index falls 1.06%

  • Stock market update: Power stocks down as market rises

  • Gainers & Losers: Trent, Tata Technologies among 11 stocks in action on Tuesday

  • PNB Housing shares zoom 10% after asset quality improves in Q4, profit rises 25% YoY

  • HDFC Bank races past Goldman Sachs in market value, signals post-merger strength

  • Mutual funds boost holdings in this multibagger stock to all-time high in March quarter. Do you own it?

  • Stagnant since listing, Afcons stock faces its first post-IPO test this week

  • IPO Watch: Canara HSBC Life Insurance files draft papers with SEBI

  • M&M sets board meeting date to declare Q4 results 2025, dividend

  • Ashish Kacholia adds 8 new stocks, hikes stakes in 4 firms in Q4 amid market correction

  • Defence stocks rally up to 9% for second straight day after Pakistan defence minister says Indian military incursion is imminent

  • Stock market update: Mining stocks up as market rises

  • Sensex, Nifty rally over 12% in April: Is Indian stock market being too optimistic as real risks linger?

  • Is the white metal ready for a catch-up rally?

  • RIL logs highest one-day gain in 11 months, could rise 11-22% more